Miramistin, can inhibit or kill influenza A, human papilloma viruses that cause warts, coronaviruses, adenoviruses, and human immunodeficiency virus (HIV). The potion is much less toxic to human cells than conventional antiseptics such as cyclohexamide and cetylpyridinium chloride, and is also biodegradable. It can be used against Candida and Aspergillus species, and also kills bacteria, including Stарhуlососсus, Proteus and Klebsiella as well as the bugs that cause syphilis and gonorrhoea.
This report contains market size and forecasts of Miramistin in global, including the following market information:
Global Miramistin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Miramistin Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Miramistin companies in 2021 (%)
The global Miramistin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Miramistin include INFAMED, Georgia, Darnitsa and Tocopharm Co, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Miramistin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Miramistin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Miramistin Market Segment Percentages, by Type, 2021 (%)
Powder
Solution
Global Miramistin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Miramistin Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical Intermediates
Antibacterial Agents
Antiseptic
Others
Global Miramistin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Miramistin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Miramistin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Miramistin revenues share in global market, 2021 (%)
Key companies Miramistin sales in global market, 2017-2022 (Estimated), (MT)
Key companies Miramistin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
INFAMED
Georgia
Darnitsa
Tocopharm Co